Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Weixuan Zhao & Hongmei Meng. (2022) Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population. Bioengineered 13:3, pages 7709-7745.
Read now
Read now
Carlos Eduardo Silvado, Vera Cristina Terra & Carlos Alexandre Twardowschy. (2018) CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. Pharmacogenomics and Personalized Medicine 11, pages 51-58.
Read now
Read now
Articles from other publishers (30)
Valentina Urzì Brancati, Tiziana Pinto Vraca, Letteria Minutoli & Giovanni Pallio. (2023) Polymorphisms Affecting the Response to Novel Antiepileptic Drugs. International Journal of Molecular Sciences 24:3, pages 2535.
Crossref
Crossref
Bharti Gupta, Pankhuri Misra, Avaranjika Karuppusamy, Dharshna Balamurugan, Maneet Parewa, Maneela Tomar, Shruti Rai, Himani Vashishth, Satarupa Sadhukhan, Navin Kumar Singh, Munmun Koley & Subhranil Saha. (2022) Individualized Homeopathic Medicines as Adjunctive Treatment of Pediatric Epilepsy: A Double-Blind, Randomized, Placebo-Controlled Trial. Homeopathy.
Crossref
Crossref
Shitao Wang, Xuemei Cai, Shiyong Liu, Qixin Zhou, Ting Wang, Sunbing Du, Dan Wang, Fei Yang, Qian Wu & Yanbing Han. (2022) A novel BCL11A polymorphism influences gene expression, therapeutic response and epilepsy risk: A multicenter study. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Aminah Alchakee, Munazza Ahmed, Leen Eldohaji, Hamid Alhaj & Maha Saber-Ayad. (2022) Pharmacogenomics in Psychiatry Practice: The Value and the Challenges. International Journal of Molecular Sciences 23:21, pages 13485.
Crossref
Crossref
Pei Xi, Hao Wang, Zihua Zhong, Shihui Liu, Jiaxuan Tang, Chunli Guo & Penggao Dai. (2022)
rs144012689
is a highly specific representative marker of
HLA-B*15:02
in the Chinese population
. Pharmacogenomics 23:15, pages 835-845.
Crossref
Crossref
Zeynep Gizem Todurga Seven, Deniz Özen & Sibel Özyazgan. 2022. Biomarkers in Medicine. Biomarkers in Medicine
309
377
.
Marta Vázquez & Pietro Fagiolino. (2021) The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug‐resistant epilepsy. Epilepsia Open 7:S1.
Crossref
Crossref
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Carlo Lovati, Davide Bertuzzo, Florindo d’Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Francesca Schiano Di Cola, Angelo Ranieri, Bruno Colombo, Francesco Bono, Maria Albanese, Sabina Cevoli, Piero Barbanti, Giulia Pierangeli, Chiara Capogrosso, Marco Aguggia, Daniele Spitaleri, Stefano Messina, Francesca Trogu, Fabio Frediani, Ottavia Baldi, Renata Rao, Gennaro Alfieri, Roberta Messina, Massimo Filippi & Fabio Bombardieri.. (2021) Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study. European Journal of Neurology 29:4, pages 1198-1208.
Crossref
Crossref
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Giulia Pierangeli, Carlo Lovati, Marco Aguggia, Florindo d’Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Renata Rao, Francesco Bono, Angelo Ranieri, Maria Albanese, Sabina Cevoli & Piero Barbanti. (2021) Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study). The Journal of Headache and Pain 22:1.
Crossref
Crossref
Shitao Wang, Liang Zhou, Chenglu He, Dan Wang, Xuemei Cai, Yanying Yu, Liling Chen, Di Lu, Ligong Bian, Sunbing Du, Qian Wu & Yanbing Han. (2021) The Association Between STX1B Polymorphisms and Treatment Response in Patients With Epilepsy. Frontiers in Pharmacology 12.
Crossref
Crossref
Teresa Iannaccone, Carmine Sellitto, Valentina Manzo, Francesca Colucci, Valentina Giudice, Berenice Stefanelli, Antonio Iuliano, Giulio Corrivetti & Amelia Filippelli. (2021) Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters. Pharmaceuticals 14:3, pages 204.
Crossref
Crossref
Astrid J Rodriguez-Acevedo, Louisa G Gordon, Nicola Waddell, Georgina Hollway & Lata Vadlamudi. (2021) Developing a gene panel for pharmacoresistant epilepsy: a review of epilepsy pharmacogenetics. Pharmacogenomics 22:4, pages 225-234.
Crossref
Crossref
Anastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, Anastasia Samsonova & Raul R. Gainetdinov. (2020) Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders. Heliyon 6:5, pages e03990.
Crossref
Crossref
Rajveer Singh, Kamalesh Chakravarty, Jitupam Baishya, Manoj K. Goyal & Parampreet Kharbanda. (2020) Management of Refractory Epilepsy. International Journal of Epilepsy 06:01, pages 15-23.
Crossref
Crossref
Kyung Wook Kang, Wonkuk Kim, Yong Won Cho, Sang Kun Lee, Ki-Young Jung, Wonchul Shin, Dong Wook Kim, Won-Joo Kim, Hyang Woon Lee, Woojun Kim, Keuntae Kim, So-Hyun Lee, Seok-Yong Choi & Myeong-Kyu Kim. (2019) Genetic characteristics of non-familial epilepsy. PeerJ 7, pages e8278.
Crossref
Crossref
Malek Chouchi, Hedia Klaa, Ilhem Ben-Youssef Turki & Lamia Hila. (2019)
ABCB1
Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population
. Disease Markers 2019, pages 1-16.
Crossref
Crossref
Nada Božina, Ivana Šušak Sporiš, Tamara Božina, Iva Klarica-Domjanović, Ante Tvrdeić & Davor Sporiš. (2019) Pharmacogenetics and the treatment of epilepsy: what do we know?. Pharmacogenomics 20:15, pages 1093-1101.
Crossref
Crossref
Boulenouar Mesraoua, Dirk Deleu, Dimitri M. Kullmann, Ashok K. Shetty, Paul Boon, Emilio Perucca, Mohamad A. Mikati & Ali A. Asadi-Pooya. (2019) Novel therapies for epilepsy in the pipeline. Epilepsy & Behavior 97, pages 282-290.
Crossref
Crossref
Piero Perucca & Emilio Perucca. (2019) Identifying mutations in epilepsy genes: Impact on treatment selection. Epilepsy Research 152, pages 18-30.
Crossref
Crossref
Xian-min ShenJin Cheng. (2019)
Effects of
MDR1
(C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs
. DNA and Cell Biology 38:3, pages 250-255.
Crossref
Crossref
V. Misra, V. G. Srivatsa & E. S. Krishnamoorthy. 2019. Pediatric Neuropsychiatry. Pediatric Neuropsychiatry
189
204
.
M. Chouchi, W. Kaabachi, K. Tizaoui, R. Daghfous, S.E. Aidli & L. Hila. (2018) The HLA-B*15:02 polymorphism and Tegretol ® -induced serious cutaneous reactions in epilepsy: An updated systematic review and meta-analysis. Revue Neurologique 174:5, pages 278-291.
Crossref
Crossref
Piero Perucca, Ingrid E Scheffer & Michelle Kiley. (2018) The management of epilepsy in children and adults. Medical Journal of Australia 208:5, pages 226-233.
Crossref
Crossref
Simona Balestrini & Sanjay M. Sisodiya. (2018) Pharmacogenomics in epilepsy. Neuroscience Letters 667, pages 27-39.
Crossref
Crossref
Renzo GuerriniEmilio Perucca. (2018) Genetic testing to prevent adverse reactions to antiepileptic drugs. Neurology 90:4, pages 155-156.
Crossref
Crossref
Armond Daci, Adnan Bozalija, Fisnik Jashari & Shaip Krasniqi. (2018) Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency. International Journal of Molecular Sciences 19:1, pages 122.
Crossref
Crossref
Malek Chouchi, Wajih Kaabachi, Hedia Klaa, Kalthoum Tizaoui, Ilhem Ben-Youssef Turki & Lamia Hila. (2017) Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis. BMC Neurology 17:1.
Crossref
Crossref
Davide Mei, Elena Parrini, Carla Marini & Renzo Guerrini. (2017) The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients. Molecular Diagnosis & Therapy 21:4, pages 357-373.
Crossref
Crossref
Ali A. Asadi-Pooya, Michael R. Sperling, Steve Chung, Pavel Klein, Anyzeila Diaz, Sami Elmoufti, Jimmy Schiemann & John Whitesides. (2017) Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study. Epilepsy Research 131, pages 70-75.
Crossref
Crossref
Piero Perucca, Ingrid E. Scheffer, A. Simon Harvey, Paul A. James, Sebastian Lunke, Natalie Thorne, Clara Gaff, Brigid M. Regan, John A. Damiano, Michael S. Hildebrand, Samuel F. Berkovic, Terence J. O?Brien & Patrick Kwan. (2017) Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy. Epilepsy Research 131, pages 1-8.
Crossref
Crossref